Mutagenicity of anticancer drugs in mammalian germ cells

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 355, Issue 1-2, 1996, Pages 209-234

  Witt, Kristine L ^a,b   Bishop, Jack B ^b  

^a OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

genetic toxicity; human risk; mouse; mutation; oocyte; spermatocyte

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; LOMUSTINE; MELPHALAN; MERCAPTOPURINE; MITOMYCIN; MITOXANTRONE; PROCARBAZINE; SEMUSTINE; THIOTEPA; TROFOSFAMIDE; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; FEMALE; GERM CELL; HUMAN; HUMAN CELL; MALE; MUTAGENICITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; REVIEW; SPERMATOCYTE;

ANIMALIA; MAMMALIA;

EID: 0030591664     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(96)00029-2     Document Type: Article

References (186)

1. Aardema, M.J., J.B. Mailhes and R.J. Preston (1992) Status of the mouse metaphase II oocyte assay for detecting chemicals which induce aneuploidy in germ cells, Environ. Mol. Mutagen., 19(Suppl 20), 1.
2. Adler, I-D. (1973) Cytogenetic effect of mitomycin C on mouse spermatogonia, Mutation Res., 21, 20-21.
3. Adler, I-D. (1974) Comparative cytogenetic study after treatment of mouse spermatogonia with mitomycin C, Mutation Res., 23, 369-379.
4. Adler, I-D. (1978) The cytogenetic heritable translocation test, Biol. Zeuralblatt, 97, 441-451.
5. Adler, I-D. (1980) New approaches to mutagenicity studies in animals for carcinogenic and mutagenic agents. I, Modification of the heritable translocation test, Teratogenesis, Mutagen. Carcinogen., 1, 75-86.
6. Adler, I-D. (1984) Cytogenetic tests in mammals, in: S. Venitt and J.M. Parry (Eds.), Mutagenicity Testing, A Practical Approach, IRL Press, Oxford, Washington, DC, pp. 275-306.
7. Adler, I.-D. and A. El-Tarras (1989) Clastogenic effects of cis-diamminedichloroplatinum. I. Induction of chromosomal aberrations in somatic and germinal cells of mice, Mutation Res., 211, 131-137.
8. Adler, I.-D. and A. El-Tarras (1990) Clastogenic effects of cis-diamminedichloroplatinum. II. Induction of chromosomal aberrations in primary spermatocytes and spermatogonial stem cells of mice, Mutation Res., 243, 173-178.
9. Adler, I-D., C. Erbelding and B. Lutzenberger (1984) Procarbazine- and ethylnitrosourea (ENU)-induced heritable translocations in the mouse, Mutation Res., 130, 175-176.
10. Adler, I-D., G. Schriever-Schwemmer and U. Kleisch (1994) Clastogenicity of trophosphamide in somatic and germinal cells of mice, Mutation Res., 307, 237-243.
11. Albanese, R. (1987a) Induction and transmission of chemically induced chromosome aberrations in female germ cells, Environ. Mol. Mutagen., 10, 231-243.
12. Albanese, R. (1987b) Mammalian male germ cell cytogenetics, Mutagenesis, 2(2), 79-85.
13. Allen, J.W., G.K. DeWeese, J.B. Gibson, P.A. Poorman and M.J. Moses (1987) Synaptonemal complex damage as a measure of chemical mutagen effects on mammalian germ cells, Mutation Res., 190, 19-24.
14. Allen, J.W., P.A. Poorman, L.C. Backer, J.B. Gibson, B. Westbrook-Collins and M.J. Moses (1988) Synaptonemal complex damage as a measure of genotoxicity at meiosis, Cell. Biol. Toxicol., 4, 487-494.
15. Anderson, R.D. and N.A. Berger (1994) Mutagenicity and carcinogenicity of topoisomerase-interactive agents, Mutation Res., 309, 109-142.
16. Anderson, D., J.B. Bishop, R.C, Garner, P. Ostrosky-Wegman and P.B. Selby (1995) Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks, Mutation Res., 330, 115-181.
17. Ashby, J., E.W. Vogel, H. Tinwell, R.D. Callander and D.E. Shuker (1993) Mutagenicity to salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency, Mutation Res., 286, 101-109.
18. Au, W.W. and T.C. Hsu (1980) The genotoxic effects of adriamycin in somatic and germinal cells of the mouse, Mutation Res., 79, 351-361.
19. Aubier, F., F. Flamant, R. Brauner, J.M. Caillaud, J.M. Chaussain and J. Lemerle (1989) Male gonadal function after chemotherapy for solid tumors in childhood, J. Clin. Oncol., 7, 304-309.
20. Auerbach, C. and D.S. Falconer (1949) A new mutant in the progeny of mice treated with nitrogen mustard, Nature, 163, 678-679.
21. Auerbach, C. and J.M. Robson (1946) Chemical production of mutations, Nature, 157, 302.
22. Auerbach, C., J.M. Robson and J.G. Carr (1947) The chemical production of mutations, Science, 105, 243-247.
23. Backer. L.C., J.B. Gibson, J.J. Moses and J.W. Allen (1988) Synaptonemal complex damage in relation to meiotic chromosome aberrations after exposure of male mice to cyclophosphamide, Mutation Res., 203, 317-330.
24. Becker, K. and J. Schoneich (1982) Expression of genetic damage induced by alkylating agents in germ cells of female mice, Mutation Res., 92, 447-464.
25. Bishop, J.B. and R.L. Kodell (1980) The heritable translocation assay; its relationship to assessment of genetic risks for future generations, Teratogen. Carcinogen. Mutagen., 1, 305-332.
26. Bishop, J.B. and J.S. Wassom (1986) Toxicological review of busulfan (Myleran), Mutation Res., 168, 15-45.
27. Bishop, J.B. and K.L. Witt (1995) In Vivo Germ Cell Mutagenesis Assays, in: Phillips and Venitt (Eds.), Environmental Mutagenesis. Bios Scientific Publishers, Ltd., Oxford, UK, pp. 155-179.
28. Bishop, J.B., R.L. Kodell, E.B. Whorton and O.E. Domon (1983) Dominant lethal test response with IMS and TEM using different combinations of male and female stocks of mice, Mutation Res., 121, 273-280.
29. Bishop, J.B., L.A. Hughes, J.C. Seely and W.M. Generoso (1995) Differential response of male and female mice to the reproductive and developmental effects of actinomycin-D, Environ. Mol. Mutagen., 25 (Suppl. 25), p. 5.
30. Bollag, W. (1954) Cytostatics in pregnancy, Scheiz. Med. Wschr., 84, 393-395.
31. Brandriff, B.F., M.L. Meistrich, L.A. Gordon, A.V. Carrano and J.C. Liang (1994) Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine and prednisone) therapy with and without radiotherapy, Human Genet. Mar., 93(3), 295-299.
32. Brewen, J.G. (1971) Human genetic risk assessment for chemical substances, Reg. Toxicol. Pharmacol., 1, 78-83.
33. Brusick, D.J., H.N.B. Gopalan, E. Heseltine, J.W. Huismans and P.H.M. Lohman (1992) Assessing the Risk of Genetic Damage, London, Hodder and Stoughton.
34. Bucci, L.R. and M.L. Meistrich (1987) Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations, Mutation Res., 176, 259-268.
35. Charles, D. and A. Leonard (1978) Mutagenicity tests with phenylbutazone in mammals, Toxicol. Lett., 2, 225-230.
36. Dean, B.J., D. Anderson and R.J. Sram (1981) Mutagenicity of selected chemicals in the mammalian dominant lethal assay, in: Comparative Chemical Mutagenesis, Environ. Sci. Res., 24, 487-538.
37. DeLuca, J.C., F.N. Dulout and J.M. Andrieu (1988) The induction of reciprocal translocations in mouse germ cells by chemicals and ionizing radiations, Mutation Res., 202, 65-70.
38. Ehling, U.H, (1971) Comparison of radiation- and chemically induced dominant lethal mutations in male mice, Mutation Res., 11, 35-44.
39. Ehling, U.H. (1974) Differential spermatogenic response of mice to the induction of mutations by antineoplastic drugs, Mutation Res., 26, 285-295.
40. Ehling, U.H. and H.V. Malling (1968) 1,4-di(Methanesulfonoxy)butane (Myleran) as a mutagenic agent in mice, Genetics, 60, 174-175.
41. Ehling, U.H. and A. Neuhauser (1979) Procarbazine-induced specific locus mutations in male mice, Mutation Res., 59, 245-256.
42. Ehling, U.H. and A. Neuhauser-Klaus (1988a) Induction of specific-locus and dominant lethal mutations by cyclophosphamide and combined cyclophosphamide-radiation treatment in male mice, Mutation Res., 199, 21-30.
43. Ehling, U.H. and A. Neuhauser-Klaus (1988b) Induction of specific-locus mutations in female mice by 1-ethyl-1-nitrosourea and procarbazine, Mutation Res., 202, 139-146.
44. Ehling, U.H. and A. Neuhauser-Klaus (1989) Induction of specific-locus and dominant lethal mutations in male mice by chlormethine, Mutation Res., 227, 81-89.
45. Ehling, U.H. and A. Neuhauser-Klaus (1991) Induction of specific-tocus and dominant lethal mutations in male mice by busulfan, Mutation Res., 249, 285-292.
46. Ehling, U.H. and A. Neuhauser-Klaus (1994) Induction of specific-locus and dominant lethal mutations in male mice by trophosphamide, Mutation Res., 307, 229-236.
47. Ehling, U.H., D.G. Doherty and H. Mailing (1972) Differential spermatogenic response of mice to the induction of dominant lethal mutations by n-propyl methanesulfonate and isopropyl methanesulfonate, Mutation Res., 15, 175-184.
48. Ehling, U.H., L. Machemer, W. Buselmaier, J. Dycka, H. Frohberg, J. Kratochvilova, R. Lang, D. Lorke, D. Muller, J. Peh, G. Rohrborn, R. Roll, M. Schulze-Schencking and W. Wiemann (1978) Standard protocol for the dominant lethal test on male mice set up by the Working Group 'Dominant Lethal Mutations of the ad hoc Committee Chemogenetics', Arch. Toxicol., 39, 173-185.
49. Ehling, U.H., J. Kratochvitova, W. Lehmacher and A. Neuhauser-Klaus (1988c) Mutagenicity testing of vincristine sulfate in germ cells of male mice, Mutation Res., 209, 107-113.
50. Epstein, S., E. Arnold, J. Andrea, W. Bass and J. Bishop (1972) Detection of chemical mutagens by the dominant lethal assay in the mouse, Toxicol. Appl. Pharmacol., 23, 288-325.
51. Fawcett, D.W., W.A. Anderson and D.M. Phillips (1971) Morphologenetic factors influencing the shape of the sperm head, Dev. Biol., 26, 220-251.
52. Feingold, L., D.A. Savitz and E.M. John (1992) Use of a job-exposure matrix to evaluate parental occupation and childhood cancer, Cancer Causes Control, 3, 161-169.
53. Foureman, P., J.M. Mason, R. Valencia and S. Zimmering (1994) Chemical Mutagenesis Testing in Drosophila. X. Results of 70 coded compounds tested for the National Toxicology Program, Environ. Mol. Mutagen., 23, 208-227.
54. Fox, M. and D. Scott (1980) The genetic toxicology of nitrogen and sulphur mustard, Mutation Res., 75, 131-168.
55. Gabrail, N.Y. (1989) Acute leukemia after adjuvant chemotherapy for breast cancer, Mo. Med., 86, 689-690.
56. Generoso, W.M. and Piegorsch, W.W. (1993) Dominant lethal tests in male and female mice, in: Methods in Toxicology, J.J. Heindel and R. Chapin (Eds.), Academic Press, pp. 124-142.
57. Generoso, W.M. and W.L. Russell (1969) Strain and sex variations in the sensitivity of mice to dominant lethal induction with ethyl methanesulfonate, Mutation Res., 8, 589-598.
58. Generoso, W.M., S.W. Huff and S.K. Stout (1971) Chemically-induced dominant lethal mutations and cell killing in mouse oocytes in the advanced stages of follicular development, Mutation Res., 11, 411-420.
59. Generoso, W.M., R.J. Preston and J.G. Brewen (1975) 6-Mercaptopurine: an inducer of cytogenetic and dominant lethal effects in premeiotic and early meiotic germ cells of male mice, Mutation Res., 28, 437-447.
60. Generoso, W.M., K.T. Cain, S.W. Huff and D.G. Gosslee (1978a) Heritable-Translocation Test in Mice, in: A. Hollaender and F.J. de Serres (Eds.), Chemical Mutagens, Vol. 5. Plenum Press, pp. 55-77.
61. Generoso, W.M., K.T. Cain, S.W. Huff and D.G. Gosslee (1978b) Inducibility by chemical mutagens of heritable translocations in male and female germ cells of mice, in: W.G. Flamm and M.A. Mehlman (Eds.), Advances in Modern Toxicology, Vol. 5, Hemisphere, Washington, DC, pp. 109-129.
62. Generoso, W.M., J.B. Bishop, D.G. Goslee, G.W. Newell, C.J. Sheu and E. von Halle (1980) Heritable translocation test in mice, Mutation Res, 76, 191-215.
63. Generoso, W.M., B. Cattanach and A.M. Malashenko (1981) Mutagenicity of selected chemicals in mammals: The Heritable Translocation Test. in: F.J. de Serres and M. D. Shelby (Eds.), Comparative Chemical Mutagenesis, Plenum Press, New York, pp. 681-707.
64. Generoso, W.M., K.T. Cain, L.A. Hughes and L.B. Foxworth (1989) A restudy of the efficacy of adriamycin in inducing dominant lethals in mouse spermatogonia stem cells, Mutation Res., 226, 61-64.
65. Generoso, W.M., K.L. Witt, K.T. Cain, L. Hughes, A-M. Lockhart and M.D. Shelby (1995) Dominant lethal and heritable translocation tests with chlorambucil and melphalan in male mice, Mutation Res., 345, 167-180.
66. Genesca, A., L. Barrios, R. Miro, M.R. Caballin, J. Benet, C. Fuster, X. Bonfill and J. Egozcue (1990a) Lymphocyte and sperm chromosome studies in cancer-treated men, Hum. Genet., 84, 353-355.
67. Genesca, A., J. Benet, M.R. Caballin, R. Miro, J.R. Germa and J. Egozcue (1990b) Significance of structural chromosome aberrations in human sperm: analysis of induced aberratons, Hum. Genet., 85, 495-499.
68. Genesca, A., R. Miro, M.R. Caballin, J. Benet, J.R. Germa and J. Egozcue (1990c) Sperm chromosome studies in individuals treated for testicular cancer, Hum. Reprod., 5, 286-290.
69. Genesca, A., M.R. Caballin, R. Miro, J. Benet, J.R. Germa and J. Egozcue (1992) Repair of human sperm chromosome aberrations in the hamster egg. Hum. Genet., 89, 181-186.
70. Guersy, P., G. Lenoir and M. Broyer (1978) Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome, J. Pediatr., 92, 299-303.
71. Hakovirta, H., M. Parvinen and J. Lahdetie (1993) Effects of etoposide on stage specific DNA synthesis during rat spermatogenesis, Mutation Res., 301, 189-193.
72. Handel, M.A. (1987) Genetic control of spermatogenesis in mice, in: W. Henning (Ed.), Spermatogenesis, Genetic Aspects, Results and Problems in Cell Differentiation, Vol. 15, Springer, Berlin, Heidelberg, pp. 1-62.
73. Hassold, T. and A. Matsuyama (1979) Origin of trisomies in human spontaneous abortions. Hum. Genet., 46, 285-294.
74. Hawkins, M.M. (1991) Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J. Natl. Cancer Inst., 83(22), 1643-1650.
75. Heller, R.H. and H.W. Jones Jr. (1964) Production of ovarian dysgenesis in the rat and human by sufulfan, Am. J. Obstet. Gynecol., 89, 414-420.
76. Hemsworth, B.N. and H. Jackson (1962) Effect of 'busulphan' on the fetal gonad, Nature (Lond.), 195, 816-817.
77. Henne, T. and D. Schmahl (1985) Occurrence of second primary malignancies in man; a second outlook. Cancer Treat. Rev., 12, 77-94.
78. Henry-Amar, M. and P.Y. Dietrich (1993) Acute leukemia after the treatment of Hodgkin's disease, Hamatol. Oncol. Clin. North Am. 7, 369-387.
79. Hook, E.B. (1985) The impact of aneuploidy upon public health: mortality and morbidity associated with human chromosome abnormalities, in: V.L. Dellarco, P.E. Voytek and A. Hollaender (Eds.), Aneuploidy - Etiology and Mechanisms, Plenum Press, New York, pp. 7-33.
80. IARC Suppl. 7 (1987) Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs Vols. 1 to 42. Lyon: International Agency for Research on Cancer.
81. IARC (1990) Monographs on the evaluation of carcinogenic risks to humans, Pharmaceutical Drugs, Vol. 50, pp. 123-142.
82. Jaffe, N, M.P. Sullivan, H. Ried, H. Boren, R. Marshall, M. Meistrich, M. Maor and M. da Cunha (1988) Male reproductive function in long-term survivors of childhood cancer, Med. Pediatr. Oncol., 16, 241-247.
83. James, D.A. and D.M. Smith (1982) Analysis of results from a collaborative study of the dominant lethal assay, Mutation Res., 97, 303-314.
84. Jenkinson, P.C., D. Anderson and S.D. Gangolli (1987) Increased incidence of abnormal foetuses in the offspring of cyclophosphamide-treated male mice, Mutation Res., 188, 57-62.
85. Johnson, P.M. and S.E. Lewis (1981) Mouse spermatogonia exposed to a high, multiply fractionated dose of a cancer chemotherapeutic drug: mutation analysis by electrophoresis, Mutation Res., 81, 197-202.
86. Kallio, M. and J. Lahdetie (1993) Analysis of micronuclei induced in mouse early spermatids by mitomycin C, vinblastine sulfate, or etoposide using fluorescence in situ hybridization, Mutagenesis, 8(6), 561-567.
87. Kallio, M., T. Sjoblom and J. Lahdetie (1995) Effects of vinblastine and colchicine on male rat meiosis in vivo: disturbances in spindle dynamics causing micronuclei and metaphase arrest, Environ. Mol. Mutagen., 25, 106-117.
88. Katoh, M.A., K.T. Cain, L.A. Hughes, L.B. Foxworth, J.B. Bishop and W.M. Generoso (1990) Female-specific dominant lethal effects in mice, Mutation Res., 230, 205-217.
89. Kligerman, A.D., J.B. Bishop. G.L. Erexson, H.C. Price, R.W. O'Connor, D.L. Morgan and E, Zeiger. (1994) Cytogenetic and germ cell effects of phosphine inhalation by rodents: II. Subacute exposures to rats and mice, Environ. Mol. Mutagen., 24, 301-306.
90. Lahdetie, J. (1983) Micronuclei induced during meiosis by ethyl methanesulfonate, cyclophosphamide and dimethylbenzanthracene in male rats, Mutation Res., 120, 257-260.
91. Lahdetie, J. (1988) Induction and survival of micronuclei in rat spermatids. Comparison of two meiotic micronucleus techniques using cyclophosphamide, Mutation Res., 203, 47-53.
92. Lahdetie, J., A. Keiski, A. Suutari and J. Toppari (1994) Etoposide (VP-16) is a potent inducer of micronuclei in male rat meiosis: Spermatid micronucleus test and DNA flow cytometry after etoposide treatment. Environ. Mol. Mutagen., 24, 192-202.
93. Lee, I.P. and R.L. Dixon (1972) Antineoplastic drug effects on spermatogenesis studied by velocity sedimentation cell separation, Toxicol. Appl. Pharmacol., 23, 20-41.
94. Leonard, A., G.H. Deknudt and G. Linden (1971) Failure to detect meiotic chromosome re-arrangements in male mice given chemical mutagens, Mutation Res., 13, 89-92.
95. Leopardi, P., A. Zijno, B. Bassani and F. Pacchierotti (1993) In vivo studies on chemical induced aneuploidy in mouse somatic and germinal cells, Mutation Res., 287, 119-130.
96. Lewis, S.E. (1991) The biochemical specific-locus test and a new multiple-endpoint mutation detection system: considerations for genetic risk assessment, Environ. Mol. Mutagen., 18, 303-306.
97. Liang, J.C. and K.L. Satya-Prakash (1985) Induction of aneuploidy by mitotic arrestants in mouse bone marrow, Mutation Res., 155, 61-70.
98. Liang, J.C., D.A. Sherron and D. Johnston (1986) Lack of correlation between mutagen-induced chromosomal univalency and aneuploidy in mouse spermatocytes, Mutation Res., 163, 285-297.
99. Machemer, L. and R. Hess (1971) Comparative dominant lethal studies with phenylbutazone, thio-tepa and MMS in the mouse, Experientia, 27, 1050-1052.
100. Machemer, L. and D. Lorke (1978) Mutagenicity studies with praziquantel, a new antihelmintic drug, in mammalian systems, Arch. Toxicol., 39, 187-197.
101. Mailhes, J.B. and F. Marchetli (1994) The influence of postovulatory ageing on the retardation of mouse oocyte maturation and chromosome segregation induced by vinblastine, Mutagenesis 9, 541-545.
102. Mailhes, J.B., R.J. Preston, Z.P. Yuan and H.S. Payne (1988) Analysis of mouse metaphse II oocytes as an assay for chemically induced aneuploidy. Mutation Res., 198, 145-152.
103. Mailhes, J.B., M.J. Aardema and F. Marchetti (1993) Investigation of aneuploidy induction in mouse oocytes following exposure to vinblastine-sulfate, pyrimethamine, diethylstilbestrol diphosphate, or chloral hydrate, Environ. Mol. Mutagen., 22, 107-114.
104. Mailhes, J.B., F. Marchetti, G.L. Phillips and D.R. Barnhill (1994) Preferential pericentric lesions and aneuploidy induced in mouse oocytes by the topoisomerase II inhibitor etoposide. Teratogen. Carcinogen. Mutagen., 14, 39-51.
105. Malashenko, A.M. and P. Goetz (1981) Cytogenetic analysis of translocations induced by the chemical mutagen thio-tepa in spermatids of male mice, Folia Biol., 27, 178-185.
106. Malashenko, A.M., K.K. Semenov, G.P. Selezneva and N.I. Surkova (1978) Studies of mutagenic effect of chemical compounds in laboratory mice, Genetika, 14, 52-61.
107. Manandhar, M., L. Dulak, J. Allen, M.J. Iotropoulos and J.F. Noble (1982) Evaluation of antineoplastic agent mitoxantrone hydrochloride in a battery of mutagenicity tests, Environ. Mutagen., 4, 349-350.
108. Manca, A., B. Bassani, A. Russo and F. Pacchierotti (1990) Origin of aneuploidy in relation to disturbances of cell-cycle progression. I: Effects of vinblastine on mouse bone marrow cells, Mutation Res., 229, 29-36.
109. Marmor, D. (1993) Fertility after cytostatic treatments, Contracept. Fertil. Sex, 21, 739-743.
110. Marmor, D., F. Grob-Menendez, F. Duyck and D. Delafontaine (1992) Very late return of spermatogenesis after chlorambucil therapy: case reports, Fertil. Steril., 58, 845-846.
111. Mattei, J.F., M.C. Mattei, S. Ayme and F. Giraud (1979) Origin of the extra chromsome in trisomy 21, Hum. Genet., 46, 107-110.
112. Meistrich, M.L. (1993) Potential genetic risks of using semen collected during chemotherapy, Hum. Reprod., 8(1), 8-10.
113. Meistrich, M.L., M. Finch, M.F. da Cunha, U. Hacker and W.W. Au (1982) Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells, Cancer Res., 42(1), 122-31.
114. Meistrich, M.L., L.S. Goldstein and A.J. Wyrobek (1985) Longterm infertility and dominant lethal mutations in male mice treated with adriamycin, Mutation Res., 152, 53-65.
115. Meistrich, M.L., M.E. Van Beek, J.C. Liang, S.L. Johnson and J. Lu (1990) Low levels of chromosomal mutations in germ cells derived from doxorubicin-treated stem spermatogonia in the mouse, Cancer Res., 50, 370-374.
116. Meistrich, M.L., G. Wilson, B.W. Brown, M.F. da Cunha and L.I. Lipshultz (1992) Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas, Cancer, 70, 2703-2712.
117. Miller, B.M. and I-D. Adler (1992) Aneuploidy induction in mouse spermatocytes, Mutagenesis, 7(1), 69-76.
118. Mohrenweiser, H. and B. Zingg (1995) Mosaicism: the embryo as a target for induction of mutations leading to cancer and genetic disease, Environ. Mol. Mutagen., 25 (Suppl. 26), 21-29.
119. Monesi, V. (1962) Autoradiographic study of DNA synthesis and the cell cycle in spermatogonia and spermatocytes of mouse testis using tritiated thymidine, J. Cell Biol., 14, 1-18.
120. Moses, M.J., P.A. Poorman, M.E. Dresser, G.K. DeWeese and J.B. Gibson. (1985) The synaptonemal complex in meiosis: significance of induced perturbations, in: V.L. Dellarco, P.E. Voytek and A. Hollaender (Eds.), Aneuploidy: Etiology and Mechanisms, Plenum Press, New York, pp. 337-350.
121. Mulvihill, J.J. (1990) Sentinel and other mutational effects in offspring of cancer survivors, Prog. Clin. Biol. Res., 34OC, 179-186.
122. Mulvihill, J.J. and J. Byrne (1985) Offspring of long-time survivors of childhook cancer, Clin. Oncol., 4, 333-343.
123. Mulvihill, J.J. and J. Byrne (1989) Genetic counseling of the cancer survivor, Semin. Oncol. Nurs., 5, 29-35.
124. Mulvihill, J.J., E.A. McKeen, F. Rosner and M.H. Zarrabi (1987) Pregnancy outcome in cancer patients, Experience in a large cooperative group, Cancer, 60(5), 1143-1150.
125. Narod, S.A., G.R. Douglas, E.R. Nestmann, D.H. Blakey (1988) Human mutagens; evidence from paternal exposure, Environ. Mol. Mutagen., 11, 401-415.
126. Natarajan, A.T. and G. Ahnstrom. (1969) Heterochromatin and chromosome aberrations, Chromosoma, 28, 48-61.
127. Oakberg, E.F. (1956) Duration of spermatogenesis in the mouse and timing of stages of the cycle of the seminiferous epithelium, Am. J. Anat., 99, 507-516.
128. Oakberg, E.F. (1960) Irradiation damage to animals and its effect on their reproductive capacity, J. Dairy Sci., 43, 54-67.
129. Oakberg, E.F. (1975) Effects of radiation on the testis, in Handbook of Physiology, Section 7, Endocrinology 5, William Wilkins Co., Baltimore, pp. 233-243.
130. Oakberg, E.F. (1983) Germ cell toxicity: significance in genetic and fertility effects of radiation and chemicals, in: E.H.Y. Chu and W.M. Generoso (Eds.), Mutation, Cancer and Malformation, Plenum Press, New York, pp. 549-590.
131. Oakberg, E.F., C.D. Crosthwait and G.D. Raymer (1982) Spermatogenic stage sensitivity to 6-mercaptopurine in the mouse, Mutation Res., 94, 165-178.
132. Olshan, A.F. (1995) Lessons learned from epidemiologic studies of environmental exposure and genetic disease, Environ. Mol. Mutagen., 25 (Suppl. 26), 74-80.
133. Olshan, A.F. and E.M. Faustman (1993) Male-mediated developmental toxicity, Annu. Rev. Public Health, 14, 159-181.
134. Pacchierotti, F., D. Bellincampi and D. Civitareale (1983) Cytogenetic observation, in mouse secondary spermatocytes, on numerical and structural chromosome aberrations induced by cyclophosphamide in various stages of spermatogenesis, Mutation Res., 119, 177-183.
135. Parry, E.M., L. Henderson and J.M. Mackay (1995) Procedures for the detection of chemically induced aneuploidy: recommendations of a UK Environmental Mutagen Society working group, Mutagenesis. 10, 1-14.
136. Pashin, Y. V. and E.D. Ambrosieva (1984) Electrophoretic enzyme variants detected in F1 progeny of males treated by alkylating mutagen, Mutation Res., 125, 71-74.
137. Pinto, A. and S.J. Lippard (1985) Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA, Biochim. Biophys. Acta, 780, 167-180.
138. Poorman-Allen, P., L.C. Backer, I-D. Adler. B. Westbrook-Collins, M.J. Moses and J.W. Allen (1990) Bleomycin effects on mouse meiotic chromosomes, Mutagenesis, 5, 573-581.
139. Povirk, L.F. and D.E. Shuker (1994) DNA damage and mutagenesis induced by nitrogen mustards, Mutation Res., 318, 205-226.
140. Rinchik, E.M., J.W. Bangham, P.R, Hunsicker, L.A. Cacheiro, B.S. Kwon, I.J. Jackson and L.B. Russell (1990) Genetic and molecular analysis of chlorambucil-induced germ-line mutations in the mouse, Proc. Natl. Acad. Sci. USA, 87, 1416-1420.
141. Roberts, G.T., F.M. Johnson, H.V. Mailing and R.K. Sharma (1979) Action of N-isopropyl-alpha-(2-methyl-hydrazino)-p-toluamide hydrochloride (procarbazine hydrochloride) in germ tissue of mice: Dominant lethal effects, Arch. Toxicol., 41, 287-294.
142. Rodjer, S., B. Swolin, A. Weinfeld and J. Westin (1990) Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma, Cancer Genet. Cytogenet, 48, 67-73.
143. Rohrborn, G. (1970) The Activity of Alkylating Agents: I. Sensitive Mutable Stages in spermatogenesis and Oogenesis, in: F. Vogel and C. Rohrborn (Eds.), Chemical Mutagenesis in Mammals and Man, Springer-Verlag, Berlin, pp. 294-316.
144. Rudiger, H.W. (1991) Clinical, genetic and regulatory consequences of exposure to mutagens, Ann. Genet. 34, 173-178.
145. Russell, W. L. (1951) X-ray-induced mutations in mice, Cold spring Harbor Symposium in Quantitative Biology, 16, 327-336.
146. Russell, W.L. (1954) Genetic effects of radiation in mammals, in: A. Hollaender (Ed.), Radiation Biology. Vol. 1, McGraw-Hill, New York, pp. 825-859.
147. Russell, L.B. (1987) Positive genetic hazard predictions from short term tests have proved false for results in mammalian spermatogonia with all environmental chemicals so far tested. Proceedings of the International Environmental Mutagen Society, Stockholm, 1984.
148. Russell, L.B. (1989) Functional and structural analyses of mouse genomic regions screened by the morphological specific-locus test, Mutation Res., 212, 23-32.
149. Russell, L.B. (1991) Factors that affect the molecular nature of germ-line mutations recovered in the mouse specific-locus test, Environ. Mol. Mutagen., 18, 298-302.
150. Russell, L.B. and P.R. Hunsicker (1987) Study of the base analog 6-mercaptopurine in the mouse specific-locus test. Mutation Res. 176, 47-52.
151. Russell, L.B. and E.M. Rinchik (1993) Structural differences between specific-locus mutations induced by different exposure regimes in mouse spermatogonial stem cells, Mutation Res., 288, 187-195.
152. Russell, W.L. and L.B. Russell (1959) Radiation-induced genetic damage in mice, in: Progress in Nuclear Energy, Series VI. Vol. 2, Biological Sciences, Pergamon, London, pp. 179-188.
153. Russell, L.B. and W.L. Russell (1992) Frequency and nature of specific-locus mutations induced in female mice by radiations and chemicals: a review, Mutation Res., 296, 107-127.
154. Russell, L.B., P.B. Selby, E. von Halle, W. Sheridan and L. Valcovic (1981) The mouse specific locus test with agents other than radiation: Interpretation of data and recommendations for future work, Mutation Res., 86, 329-354.
155. Russell, LB. P.R. Hunsicker, N.L, Cacheiro, J.W. Banham, W.L. Russell and M.D. Shelby (1989) Chlorambucil effectively induces deletion mutations in mouse germ cells, Proc. Natl. Acad. Sci. USA, 86(10), 3704-3708.
156. Russell, L.B., W.L. Russell, E.M. Rinchik and P.R. Hunsicker (1990) Factors Affecting the Nature of Induced Mutations. Banbury Report 34: Biology of Mammalian Germ Cell Mutagenesis, Cold Spring Harbor Laboratory Press.
157. Russell, L.B., P.R. Hunsicker, N.L.A. Cacheiro and E.M. Rinchik (1992a) Genetic, cytogenetic, and molecular analyses of mutations induced by melphalan demonstrate high frequencies of heritable deletions and other rearrangements from exposure of postspermatogonial stages of the mouse, Proc. Natl. Acad. Sci. USA, 89(13), 6182-6186.
158. Russell, L.B., P.R. Hunsicker and M.D. Shelby (1992b) Melphalan, a second chemical for which specific-locus mutation induction in the mouse is maximum in early spermatids, Mutation Res., 282, 151-158.
159. Russo, A. and A.G. Levis (1991) The contribution of the mouse spermatid micronucleus assay to the detection of germinal mutagens, Prog. Clin. Biol. Res., 372, 513-520.
160. Russo, A. and A.C. Levis (1992) Detection of aneuploidy in male germ cells of mice by means of a meiotic micronucleus assay, Mutation Res., 281, 187-191.
161. Russo, A. and F. Pacchierrotti (1988) Meiotic arrest and aneuploidy induced by vinblastine in mouse oocytes, Mutation Res., 202, 215-221.
162. Russo, A., F. Pacchierotti and P. Metalli (1984) Nondisjunction induced in mouse spermatogenesis by chloral hydrate, a metabolite of trichloroethylene, Environ. Mutagen., 6, 695-703.
163. Savitz, D.A. and J. Chen (1990) Parental occupational and childhood cancer: review of epidemiologic studies, Environ. Health Perspect., 88, 325-337.
164. Schilsky, R.L., B.J. Lewis, R.J. Sherins and R.C. Young (1980) Gonadal dysfunction in patients receiving chemotherapy for cancer, Ann. Intern. Med., 93, 109-114.
165. Schleiermacher, E. (1970) The activity of alkylating agents. II. Histological and cytogenetic finding in spermatogenesis, in: Vogel, F. and G. Rohrborn (Eds.), Chemical Mutagenesis in Mammals and Man, Springer-Verlag, Berlin.
166. Schull, W.J., M. Otake and J.V. Neel (1981) Genetic effects of the atomic bombs: A reappraisal, Science, 213, 1220-1227.
167. Searle, A.G. (1975) The specific locus test in the mouse, Mutation Res., 31, 277-290.
168. Sega, G.A. (1979) Unscheduled DNA synthesis (DNA Repair) in the germ cells of male mice, Its role in the study of mammalian mutagenesis, Genetics, 92, 549-558.
169. Shafford, E.A., J.E. Kingston, J.S. Malpas, P.N. Plowman, J. Pritchard, M.O. Savage and O.B. Eden (1993) Testicular function following the treatment of Hodgkin's disease in childhood, Br. J. Cancer, 68, 1199-1204.
170. Shelby, M.D. (1994) Human germ cell mutagens, Environ. Mol. Mutagen., 23 (Suppl. 24), 30-34.
171. Shelby, M.D. (1996) Selecting chemicals and assays for assessing mammalian germ cell mutagenicity, Mutation Res., 352,159-167.
172. Sheu, C.W., J.K. Lee, C.A. Arras, R.L. Jones and K.S. Lavappa (1992) Detection of vincristine-induced hyperploidy in meiotic II metaphases of male Chinese hamster, Mutation Res., 280, 181-186.
173. Shibuya, T., T. Murota, N. Horiya, H. Matsuda and T. Hara (1993) The induction of recessive mutations in mouse primordial germ cells with N-ethyl-N-nitrosourea, Mutation Res., 290, 273-280.
174. Sotomayor, R.E. and R.B. Gumming (1975) Induction of translocations by cyclophosphamide in different germ cell stages of male mice: Cytological characterization and transmission, Mutation Res., 27, 375-388.
175. Sram, R.J. (1976) Relationship between acute and chronic exposures in mutagenicity studies in mice, Mutation Res., 41, 25-42.
176. Sudman, P.D., Rutledge, J.C., Bishop, J.B. and Generoso, W.M. (1992) Bleomycin: female-specific dominant lethal effects in mice. Mutation Res. 296, 143-56.
177. Sutton, R., A.U. Buzdar and G.N. Hortobagyi (1990) Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients, Cancer, 65, 847-850.
178. Tales, A.D. (1992) Validation studies with the micronucleus test for early spermatids of rats. A tool for detecting clastogenicity of chemicals in differentiating spermatogonia and spermatocytes, Mutagenesis, 7, 411-419.
179. Tales, A.D., A.J.J. Dietrich, N. de Vogel and A. Bos (1983) A micronucleus method for deteclion of meiotic micronuclei in male germ cells of mammals, Mutation Res., 121, 131-138.
180. Tease, C. (1992) Radiation- and chemically-induced chromosome aberrations in mouse oocytes: A comparison with effects in males, Mutation Res., 296, 135-142.
181. Therkelsen, A.J., N. Grunnet, T. Hjort, O.M. Jensen, J. Jonasson, J.G. Lauritsen, L. Lindsten and G.B, Petersen (1974) Studies on spontaneous abortions, in: A. Boue and C. Thibault (Eds.), Chromosomal Errors in Relation to Reproductive Failure, INSERM, Paris.
182. Tucker, M.A., C.N. Coleman, R.S. Cox, A. Varghese and S.A. Rosenberg (1988) Risk of second cancers after treatment for Hodgkin's disease, N. Engl. J. Med., 318, 76-81.
183. Wyrobek, A.J. (1993) Methods and concepts in detecting abnormal reproductive outcomes of paternal origin, Reproductive Toxicol., 7, 3-16.
184. Yielding, K.L. (1993) Primary and secondary risk factors for birth defects, Environ. Health Perspect., 101 (Suppl. 3), 285-290.
185. Yoon, J.S., J.M. Mason, R. Valencia, R.C. Woodruff and S. Zimmering (1985) Chemical mutagenesis testing in Drosophila: IV. Results of 45 coded compounds tested for the National Toxicology Program, Environ. Mutagen., 7, 349-367.
186. Yuan, Z.P. and J.B. Mailhes (1987) Aneuploidy determination in C-banded mouse metaphase II oocytes following cyclophosphamide treatment in vivo, Mutation Res., 179, 209-214.